GlassScriptPhysician profile
Howard L Geyer
NPI 1235298688
$10,867.28
in general payments reported to CMS, 2019-2025
26 companies · $1,754 in 2025
The $1,754 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,634 · 2020: $1,291 · 2021: $1,425 · 2022: $1,693 · 2023: $1,533 · 2024: $1,537 · 2025: $1,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,556 · Education: $223 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,555.83 |
| Education | $222.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $45.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $1,533.94 | 2019-2025 | Ingrezza, Ongentys |
| Teva Pharmaceuticals USA, INC. | $1,358.17 | 2021-2025 | Austedo Xr, Austedo, Austedo Xr |
| Kyowa Kirin, INC. | $1,351.09 | 2020-2025 | Nourianz |
| Abbvie INC. | $1,125.88 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $698.51 | 2019-2025 | Crexont, Rytary, Ongentys |
| Mdd US Operations, LLC | $641.53 | 2019-2025 | Gocovri, Gocovri, Apokyn |
| Adamas Pharmaceuticals, INC. | $542.07 | 2019-2021 | |
| Acorda Therapeutics, INC | $395.74 | 2019-2024 | Inbrija |
| Catalyst Pharmaceuticals, INC. | $359.48 | 2020-2025 | Firdapse |
| Sunovion Pharmaceuticals INC. | $334.60 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $326.40 | 2022-2025 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $325.00 | 2020-2025 | Ultomiris |
| Lundbeck LLC | $317.23 | 2019-2021 | |
| Allergan, INC. | $315.25 | 2019-2021 | |
| Medtronic, INC. | $195.69 | 2021-2025 | Percept PC Brainsense |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $188.22 | 2019-2024 | Infinity |
| Ucb, INC. | $176.88 | 2019-2021 | |
| Aquestive Therapeutics, INC. | $138.25 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $121.10 | 2024-2025 | Dysport |
| Vertical Pharmaceuticals, LLC | $89.14 | 2019 | |
| Alnylam Pharmaceuticals INC. | $85.81 | 2020-2022 | |
| Greenwich Biosciences, INC. | $82.34 | 2019-2020 | |
| Medtronic USA, INC. | $64.24 | 2019-2020 | |
| Boston Scientific Corporation | $46.47 | 2023 | Vercise |
| Merz Pharmaceuticals, LLC | $34.68 | 2025 | Xeomin |
| Avion Pharmaceuticals | $19.57 | 2023 | Dhivy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Geyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.